Skip to content

Pathogenesis of Behcet's disease

Pathogenesis of Behcet's disease

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027296
Enrollment
Unknown
Registered
2019-11-08
Start date
2019-11-07
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behcet's disease

Interventions

Behcet's disease group:Behcet??

Sponsors

Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who meet the diagnosis of Behcet's disease. Adopt the international classification criteria developed by the International Behcet's Research Group in 1990: (1) Repeated oral ulcers: Some doctors observed or patients complained of aphthous ulcers or scars, repeated attacks within >= 3 times a year. (2) Repeated genital ulcers: A doctor observed or the patient complained of genital aphthous ulcers, especially men. (3) Eye lesions: pre- and/or posterior uveitis, cell infiltration, or retinal vasculitis may be seen in the vitreous during slit lamp examination. (4) Skin lesions: nodular erythematous lesions, pseudo folliculitis, purulent papules, acne-like rash (appeared without taking glucocorticoids). (5) Acupuncture reaction positive: 20 ml sterile needle, obliquely inserted into the skin, 24-48 hours later by the doctor to determine the results. Anyone with repeated oral ulcers accompanied by 2 of the remaining 4 items can be diagnosed with this disease.

Exclusion criteria

Exclusion criteria: Other diseases (infections, tumors, and other autoimmune diseases) cause symptoms similar to Behcet's disease. Severe heart disease, cardiac insufficiency, liver dysfunction, renal insufficiency, respiratory failure, malignant tumor, gastrointestinal bleeding, etc. are not expected to complete the follow-up plan; patients with mental illness; other reasons can not take the drug on time; pregnancy and lactation Women; patients who are participating in other clinical trials; the researchers believe that other reasons are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Genetic markers;Cytokine;mRNA;Immune-related factor;DNA methylation;Non-coding RNA;Copy number variations;Immune cell ratio detection;Antinuclear antibody;Anti-endothelial cell antibody;

Countries

China

Contacts

Public ContactHongsong Yu

Zunyi Medical University

yuhongsong@163.com+86 13368394403

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026